NEW YORK (AP) _ Immunic, Inc. (IMUX) on Friday reported a loss of $17.9 million in its second quarter.

The New York-based company said it had a loss of 82 cents per share.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.

Immunic shares have declined 47% since the beginning of the year. The stock has fallen 55% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News